Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia

G. Y. Hung, T. J. Chiou, Y. L. Hsieh, P. M. Chen, B. Hwang

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

We report a nonmyeloablative allogeneic bone marrow transplant (allo-BMT) from an HLA-matched unrelated donor in a case of acute myeloid leukemia (AML), M2 with t(8;21)(q22;q22) and the presence of orbital granulocytic sarcoma (GS), who had residual tumor after conventional chemotherapy. The course of BMT was well tolerated, with no major procedure-related toxicity. The residual orbital GS regressed completely 4 months after BMT. She is currently 19 months post BMT, disease-free. To our knowledge, this is the first reported pediatric patient with AML, GS and t(8;21)(q22;q22) who received a nonmyeloablative allo-BMT.

Original languageEnglish
Pages (from-to)67-70
Number of pages4
JournalBone Marrow Transplantation
Volume29
Issue number1
DOIs
Publication statusPublished - 2002
Externally publishedYes

Keywords

  • Acute myeloid leukemia
  • Granulocytic sarcoma
  • Nonmyeloablative bone marrow transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint

Dive into the research topics of 'Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this